The economic impact of parallel imports of pharmaceuticals

Parallel import of pharmaceuticals has taken place in Denmark and the rest of the EU since the 1970s. In 2018, parallel imports accounted for 14% of turnover in the Danish market for medicinal products. Parallel-imported pharmaceuticals are original pharmaceuticals imported from another EU/EEA country where they are cheaper than in Denmark. Hence, they are the same medicinal products as the ones the original manufacturers sell in Denmark.

The study is commissioned by the Danish Association of Parallel Importers of Pharmaceuticals (Foreningen for Parallelimportører af Medicin). Read the study in English here.

Go back